[Report on the clinical evaluation of the antihypertensive effects of Urandil A VUFB].
D000328:Adult; D000368:Aged; D000584:Amiloride / Q000627:therapeutic use*; D001794:Blood Pressure; D002752:Chlorthalidone / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D004311:Double-Blind Method; D004338:Drug Combinations / Q000627:therapeutic use; D005260:Female; D006801:Humans; D006973:Hypertension / Q000188:drug therapy* / Q000503:physiopathology; D054833:Isoindoles; D008297:Male; D008875:Middle Aged; D011719:Pyrazines / Q000627:therapeutic use*; D000096926:Benzenesulfonamides
D000584:Amiloride; D002752:Chlorthalidone; D004338:Drug Combinations; D054833:Isoindoles; D011719:Pyrazines; C040679:uranidil A; D000096926:Benzenesulfonamides
Zpráva o klinickém hodnocení antihypertenzního úcinku prípravku Urandil A VUFB.